Pharmacy Podcast Network - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

Pharmacy Podcast Network — Business
Pharmacy Podcast Network

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.

Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.

Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that’s truly peer-reviewed. The future of podcasting education for Providers is “Evidence-based Podcasting” (TM) and we’re building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.

PPN is a division of RxPR, LLC. Copyright 2026

Latest Episodes:

Keep Your Poop to Yourself | GameChangers Dec 22, 2020

Show notes

Clostridioides difficile is an important cause of morbidity and mortality in the United States with over 500,000 infections annually. The Infectious Disease Society of America released a clinical quality measure focused on treatment of c diff in March 2020. A review of the diagnosis and treatment will help providers improve quality. This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today! The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

PCSK9 Inhibitors | Pharmacy Connect Podcast Dec 22, 2020

Show notes

Pharmacy Connect Podcast: PCSK9 Inhibitors Title: PCSK9 Inhibitors:Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes With Hyperlipidemia Management Special guest: Joseph Saseen, PharmD Professor and Vice Chair, Clinical and Academic Programs; Department of Clinical Pharmacy Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Anschutz Medical Campus Objectives Understand the role of PCSK9 inhibitors in the American Heart Association and the American College of Cardiology hyperlipidemia management guidelines Review the pertinent drug information and clinical benefits of the use of PCSK9 inhibitors in the treatment of hyperlipidemia. Describe the role of the pharmacist in patient education and counseling on PCSK9 inhibitors for the treatment of hyperlipidemia through motivational interviewing. CE LINK HERE: https://www.pharmacytimes.org/on-demand/pcsk9-inhibitors-understanding-the-pharmacists-role-in-patient-education-and-improving-outcomes-with-hyperlipidemia-management PTCE - Pharmacy Times Continuing Education See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Supreme Court Rules in Favor of Pharmacy | Locked On Pharmacy Dec 21, 2020

Show notes

On Dec. 10, 2020, the U.S. Supreme Court ruled 8-0 that an Arkansas law regulating how PBMs and pharmacies interact could be enforced, and was not preempted by federal law. With more than three dozen other states debating or passing such legislation, the ruling could have nationwide impact. The CEOs of national pharmacy organization were unanimous in hailing the decision. In this episode, three guests discuss the case: Rep. Buddy Carter (R-Georgia); John Vinson, CEO of the Arkansas Pharmacists Association; and Scott Knoer, Executive Vice President and CEO of the American Pharmacists Association. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Enhancing Diabetes Management: Important Technological and Therapeutic Achievements Dec 21, 2020

Show notes

For over a century, the treatments and technologies used to treat diabetes have evolved. New tools are now available to aid in diabetes management and to help patients further manage and better control their glucose levels. 1,2 Through their recently announced collaboration, Dexcom and Lilly are at the forefront of enhancing diabetes care. 3 In this episode Dr. Chad Worz and guest speakers Deirdre Ibsen and Dr. Thomas Blevins discuss these important technological and therapeutic achievements over time, as well as 2 products available from Dexcom and Lilly and how they may benefit patients with diabetes. References: Dexcom G6 Pro User Guide. https://dexcompdf.s3-us-west-2.amazonaws.com/Dexcom-G6-Pro-User-Guide.pdf. Accessed October 12, 2020. Lyumjev [Prescribing Information]. Indianapolis, IN: Lilly USA, LLC. Eli Lilly and Company. Lilly and Dexcom team up on new program to help improve diabetes management. https://provider.dexcom.com/products/dexcom-g6-pro/training-resources. Accessed October 12, 2020. Centers for Disease Control. National Diabetes Statistics Report 2020 Estimates of Diabetes and Its Burden in the United States. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed October 1, 2020. American Diabetes Association. Diabetes and Quality of Life. http://journal.diabetes.org/diabetesspectrum/00v13n1/pg48.htm. Accessed October 1, 2020. American Diabetes Association. Caring for the Caregiver. https://spectrum.diabetesjournals.org/content/17/1/37.full-text.pdf. Accessed October 15, 2020. Ali MK, Bullard KM, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med. 2013;369(3):287-288. Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D Exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66-72. American Diabetes Association. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(suppl 1):S77-S88. Hirsch IB. History of Glucose Monitoring. https://professional.diabetes.org/sites/professional.diabetes.org/files/media/db201811.pdf. Accessed October 1, 2020. White JR. A brief history of the development of diabetes medications. Diabetes Spectr. 2014;27(2):82-86. Science History Institute. Frederick Banting, Charles Best, James Collip, and John Macleod. https://www.sciencehistory.org/historical-profile/frederick-banting-charles-best-james-collip-and-john-macleod. Accessed October 1, 2020. American Diabetes Association. Timeline. https://www.diabetes.org/resources/timeline. Accessed October 9, 2020. Humalog [Prescribing Information]. Indianapolis, IN: Lilly USA, LLC. Selam J-L. Evolution of diabetes insulin delivery devices. J Diabetes Sci Technol. 2010;4(3):505-513. American Association of Diabetes Educators. Insulin Injection Know-How. https://www.diabeteseducator.org/docs/default-source/legacy-docs/_resources/pdf/general/Insulin_Injection_How_To_AADE.pdf. Accessed October 1, 2020. Hyllested-Winge J, Jensen KH, Rex J. A review of 25 years’ experience with the NovoPen® family of insulin pens in the management of diabetes mellitus. Clin Drug Investig. 2010;30(10):643-674. Eli Lilly and Company. Lilly Launches KwikPen(TM) for Humalog(R) and Humalog Mixtures [press release]. https://investor.lilly.com/news-releases/news-release-details/lilly-launches-kwikpentm-humalogr-and-humalog-mixtures. Accessed October 12, 2020. American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(suppl 1):S66-S76. Garber AJ, Handelsman Y, Grunberger G, et al. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary. Endocr Pract. 2020;26(1):107-139. Fonseca VA, Grunberger G, Anhalt H, et al. Continuous glucose monitoring: a consensus conference of the American Association of Clinical Endocrinologists and American College of Endocrinology. Endocr Pract. 2016;22(8):1008-1021. Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593-1603. Dexcom G6 Pro Unblinded Patient Guide. https://dexcompdf.s3-us-west-2.amazonaws.com/Dexcom-G6-Pro-Unblinded-Patient-Guide.pdf. Accessed October 12, 2020. Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM. https://provider.dexcom.com/industry-news/fda-authorizes-dexcom-g6-pro. Accessed October 2, 2020. Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. 2017;317(4):371-378. Beck RW, Riddlesworth TD, Ruedy K, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017;167(6):365-374. Polonsky WH, Hessler D, Ruedy KJ, Beck RW. The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: further findings from the DIAMOND randomized clinical trial. Diabetes Care. 2017;40(6):736-741. Pratley RE, Kanapka LG, Rickels MR, et al. Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial. 2020;323(23):2397-2406. Ruedy KJ, Parkin CG, Riddlesworth TD, Graham C. Continuous glucose monitoring in older adults with type 1 and type 2 diabetes using multiple daily injections of insulin: results from the DIAMOND trial. J Diabetes Sci Technol. 2017;11(6):1138-1146. Lind M, Polonsky W, Hirsch IB, et al. Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial. 2017;317(4):379-387. Frequently Asked Questions. https://provider.dexcom.com/products/dexcom-g6-pro/faqs. Accessed October 15, 2020. Dexcom Products: Dexcom G6 Pro. https://provider.dexcom.com/products/professional-cgm. Accessed October 15, 2020. How to Customize Alarm and Alerts. https://www.dexcom.com/faqs/how-to-customize-alarm-and-alerts. Accessed October 15, 2020. Trend Arrows and Treatment Decisions. https://s3-us-west-2.amazonaws.com/dexcompdf/HCP_Website/LBL015804+G6+Trend+Arrows+and+Treatment+Decisions.pdf. Accessed October 15, 2020. Why CGM? https://provider.dexcom.com/why-cgm. Accessed October 12, 2020. Pharmacy Coverage. https://provider.dexcom.com/pharmacy-coverage. Accessed October 12, 2020. Is There Reimbursement for Using Dexcom G6 Pro? https://provider.dexcom.com/faqs/there-reimbursement-using-dexcom-g6-pro. Accessed October 12, 2020. Hypoglycemia Unawareness. https://provider.dexcom.com/education-research/clinical-evidence/clinical-studies/real-time-continuous-glucose-monitoring-cgm. Accessed October 15, 2020. Garg SK, Wernicke-Panten K, Wardecki M, et al. Safety, immunogenicity, and glycemic control of insulin aspart biosimilar SAR341402 versus originator insulin aspart in people with diabetes also using insulin glargine: 12-month results from the GEMELLI 1 trial. Diabetes Technol Ther. 2020;22(7):516-526. Dexcom G6 Pro Blinded Patient Guide. https://dexcompdf.s3-us-west-2.amazonaws.com/HCP_Website/Dexcom+G6+Pro+Resources/LBL017177+Rev+004+Artwork%2C+Dexcom+G6+Pro+Blinded+Patient+Guide+US_r5_WEB.pdf. Accessed November 24, 2020. Dexcom CLARITY Diabetes Management Software. https://www.dexcom.com/clarity. Accessed May 15, 2020. Blevins T, Zhang Q, Frias JP, Jinnouchi H, Chang AM. Randomized double-blind clinical trial comparing ultra rapid lispro with lispro in a basal-bolus regimen in patients with type 2 diabetes: PRONTO-T2D. Diabetes Care. Published online July 2, 2020. doi: 10.2337/dc19-2550. Klaff L, Cao D, Dellva MA, et al. Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: results from the 26-week PRONTO-T1D study. Diabetes Obes Metab. 2020;22(10):1799-1807. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

What are ’Learning Health Systems’ special guest Allen Flynn, PhD, PharmD | FutureDose.tech Dec 17, 2020

Show notes

Todays FutureDose.tech guest is Allen Flynn, PhD & PharmD, Assistant Professor, Department of Learning Health Sciences at the University of Michigan. It has been reported that 70% of pharmacists’ time is spent on non-cognitive activities such as medication distribution. As such, the industry recognizes that more automation is needed so that pharmacists and pharmacy technicians can spend more time on patient focused activities that improve outcomes. Allen Flynn, PhD & PharmD, is one of the industry trailblazers researching and building tools that will enable pharmacists to spend more time by the bedside. Listen in as David Berkowitz and Allen Flynn discuss some of the problems that need to be solved from a clinical and technical perspective in order to automate more non-value added pharmacy tasks. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

POP CULTURE: Black Panther’s Heart-Shaped Herb | Let’s Pharmonize Dec 16, 2020

Show notes

The Black Panther proves to be more medically accurate than you might think. In this episode, our hosts are joined by friend and classmate Justin Frederick to discuss the realism of the heart-shaped herb; the source of the Black Panther's powers. We discuss ayahuasca, why cat's always land on their feet, and whether or not Cal should watch "The Black Panther," (he should.) All that and more on Let's Pharmonize! This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics! Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com. PLEASE READ: Shane and Cal are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health, A special thanks to Kelly Kerr for creating the music used in the intro and outro. Audio from Black Panther owned by Disney Studios. All Rights Reserved This episode is sponsored by: CEimpact: https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Pfizer-BioNTech Vaccine: What Pharmacists Need to Know | Locked on Pharmacy Dec 15, 2020

Show notes

Following the emergency authorization of the Pfizer-BioNTech COVID-19 vaccine we spoke with two pharmacy experts in immunization to talk about what it means for pharmacists. Our guests: Michael Hogue, president of the American Pharmacists Association, Dean of the Loma Linda University College of Pharmacy, and a member of a special work group of health care leaders advising CDC on the rollout of the COVID vaccine. Stephan Foster, PharmD, FAPhA, CAPT (Ret.), U.S. Public Health Service, and APhA liaison to the Advisory Committee on Immunization Practices. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Geoff Didn’t Know Which Was Worse | GameChangers Dec 15, 2020

Show notes

The question of acetaminophen versus ibuprofen may finally be laid to rest. A recent meta-analysis compared the efficacy and safety of ibuprofen versus acetaminophen for the treatment of fever or pain in children younger than 2 years. Is there a drug of choice? Reference: Tan E, Braithwaite I, McKinlay CJD, Dalziel SR. Comparison of Acetaminophen (Paracetamol) With Ibuprofen for Treatment of Fever or Pain in Children Younger Than 2 Years: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(10):e2022398. doi:10.1001/jamanetworkopen.2020.22398 This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today! The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Advocates for Safe IV Preparation Practices Share Their Inspiration | Future of Pharmacy Podcast Dec 15, 2020

Show notes

The Future of Pharmacy Podcast, presented by Omnicell Episode 2 Advocates for Safe IV Preparation Practices Share Their Inspiration Learn how a tragic medication error helped to inspire the formation of THRIV—a safety coalition comprised of healthcare providers, consumers and technology developers. THRIV seeks to protect patients from being harmed, and to protect caregivers from unwittingly doing harm—harm which too often stems from mistakes made when IVs are manually prepared. Our host: Ken Perez, Vice President, Healthcare Policy, Omnicell Guests: Mark Neuenschwander, Founding Director, THRIV Derek Gillespie, BPharm, MBA, Pharmacy Operations Manager, Renown Health See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

How 2020 Changed Healthcare | The Corepreneur Podcast Dec 12, 2020

Show notes

What a year 2020 has been. One thing is certain: business will never be the same again. So get ready to turn the page because 2021 is just around the corner — and it’s bringing with it all sorts of new opportunities. No more of the negative and definitely no more of the old. It is time for us to collectively look ahead. In today’s episode, we’ll discuss how journalists filter the news, what’s ahead for The Corepreneur Podcast in 2021, and what 2020 looked like for a variety of business endeavors across healthcare. This episode of the Corepreneur Podcast is sponsored by CEimpact. Learn more about CEimpact's online Continuing Education platform designed for career driven & innovative pharmacists at http://www.CEimpact.com See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Related Podcasts